Loading clinical trials...
Loading clinical trials...
Short- and Longterm Results After Intravesical Injection of Botulinum Neurotoxin Type A for Treating Therapy Refractory Overactive Bladder in Females - a Retrospective Study
Conditions
Locations
1
Switzerland
University Hospital of Zurich, Clinic for Gynaecology
Zurich, Switzerland
Start Date
January 1, 2010
Primary Completion Date
June 1, 2010
Completion Date
June 1, 2010
Last Updated
June 24, 2010
NCT04873037
NCT06198439
NCT06769854
NCT03535857
NCT06616675
NCT05719285
Lead Sponsor
University of Zurich
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions